Research Article
Impact of Intensive Lifestyle Modification on Levels of Adipokines and Inflammatory Biomarkers in Metabolically Healthy Obese Women
Table 1
Parameters at baseline (
MHO participants) vs. after 2 years (
MHO participants) of lifestyle modification, according to percentage of weight loss.
| | Weight loss group | Baseline | 2 years | |
| Age (years) | <5% | | — | | ≥5-<10% | | — | | ≥10% | | — | | All | | | |
| Body weight (kg) | <5% | | | 0.698 | ≥5-<10% | | | 0.003 | ≥10% | | | <0.001 | All | | | <0.001 |
| BMI (kg/m2) | <5% | | | 0.724 | ≥5-<10% | | | 0.005 | ≥10% | | | <0.001 | All | | | <0.001 |
| Waist circumference (cm) | <5% | | | 0.831 | ≥5-<10% | | | 0.002 | ≥10% | | | <0.001 | All | | | <0.001 |
| SBP/DBP (mmHg) | <5% | / | / | 0.285/0.302 | ≥5-<10% | 115±10/78±7 | / | 0.501/0.342 | ≥10% | 110±14/76±11 | / | 0.498/0.402 | All | / | / | 0.532/0.199 |
| Glucose (mmol/l) | <5% | | | 0.012 | ≥5-<10% | | | 0.833 | ≥10% | | | 0.376 | All | | | 0.214 |
| HbA1c (%) | <5% | | | 0.635 | ≥5-<10% | | | 0.333 | ≥10% | | | 0.801 | All | | | 0.645 |
| Total cholesterol (mmol/l) | <5% | | | 0.578 | ≥5-<10% | 4.89±0.77 | | 0.098 | ≥10% | | | 0.478 | All | | | 0.941 |
| LDL cholesterol (mmol/l) | <5% | | | 0.445 | ≥5-<10% | | | 0.902 | ≥10% | | | 0.789 | All | | | 0.501 |
| HDL cholesterol (mmol/l) | <5% | | | 0.112 | ≥5-<10% | | | 0.584 | ≥10% | | | 0.897 | All | | | 0.632 |
| Triglycerides (mmol/l) | <5% | 0.98 (0.76–1.29) | 0.98 (0.77–1.47) | 0.545 | ≥5-<10% | 0.88 (0.66–1.39) | 0.70 (0.62–0.99) | 0.003 | ≥10% | 0.93 (0.69–1.18) | 0.85 (0.72–1.08) | 0.497 | All | 0.95 (0.75–1.27) | 0.89 (0.70–1.23) | 0.132 |
|
|
Group 1: weight loss <5% (baseline, ; 2 nd year, ); Group 2: weight loss ≥5-<10% (baseline, ; 2 nd year, ); Group 3: weight loss ≥10% (baseline, ; 2 nd year, ). SBP: systolic blood pressure; DBP: diastolic blood pressure. Normal values (NV): glucose NV: 3.89-6.16; HbA1c NV: 4.0-6.0; total cholesterol NV: <5.18; LDL cholesterol NV: <3.37; HDL cholesterol NV: >1.30; triglycerides NV: <1.70. |